Literature DB >> 8268209

Aldose and aldehyde reductases from human kidney cortex and medulla.

B Robinson1, L A Hunsaker, L A Stangebye, D L Vander Jagt.   

Abstract

Aldose reductase and aldehyde reductase were purified to homogeneity from multiple samples of human kidney cortex and medulla. A single form of aldose reductase is expressed in kidney that is kinetically and immunochemically indistinguishable from aldose reductase expressed in other human tissues. The results support the conclusion that there is a single human aldose reductase, and that aldose reductase is expressed in a reduced form, characterized by high sensitivity to aldose reductase inhibitors and ability to catalyze the reduction of glucose. Aldose reductase is easily oxidized to a form that is insensitive to aldose reductase inhibitors and unable to catalyze the reduction of glucose. This form does not appear to exist in vivo, even in kidney from diabetics. There is wide variation in the level of expression of aldose reductase in kidney, especially in cortex. The immunochemically separate but similar aldehyde reductase is also expressed in kidney as a single enzyme indistinguishable from aldehyde reductase from other human tissues. Aldehyde reductase levels exceed those of aldose reductase, both in cortex and medulla.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8268209     DOI: 10.1016/0167-4838(93)90092-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

Review 1.  Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Authors:  T Baba; S Neugebauer; T Watanabe
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

2.  Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis.

Authors:  H L Rittner; V Hafner; P A Klimiuk; L I Szweda; J J Goronzy; C M Weyand
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

Review 3.  Aldose reductase and cardiovascular diseases, creating human-like diabetic complications in an experimental model.

Authors:  Ravichandran Ramasamy; Ira J Goldberg
Journal:  Circ Res       Date:  2010-05-14       Impact factor: 17.367

4.  Identification of a renal-specific oxido-reductase in newborn diabetic mice.

Authors:  Q Yang; B Dixit; J Wada; Y Tian; E I Wallner; S K Srivastva; Y S Kanwar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

5.  Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members.

Authors:  T O'connor; L S Ireland; D J Harrison; J D Hayes
Journal:  Biochem J       Date:  1999-10-15       Impact factor: 3.857

Review 6.  Aldose Reductase: An Emerging Target for Development of Interventions for Diabetic Cardiovascular Complications.

Authors:  Sravya Jannapureddy; Mira Sharma; Gautham Yepuri; Ann Marie Schmidt; Ravichandran Ramasamy
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-11       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.